Evaluation of expectations and satisfaction of the patient in the facial treatment with botulinic toxin in the upper third of the face
Avaliação das expectativas e satisfação do paciente no tratamento facial com toxina botulínica no terço superior da face
Palavras-chave:
Harmonization, Aging, Botulinum, Toxin, SatisfactionResumo
A study was conducted to survey the satisfaction of patients who underwent orofacial harmonization procedures using botulinum toxin to treat signs of aging in the upper third of the face. This is a retrospective observational study, with a sample population of 40 patients treated from November 2022 to June 2023, at the Ingá Institute, Marabá Polo, state of Pará, using data collection through a questionnaire that evaluated patient satisfaction, addressing sociodemographic aspects and questions related to patient satisfaction with the procedure performed. The data were analyzed using descriptive statistics, such as frequency, mean and deviations, and Pearson’s correlation. All analyses were performed in SPSS 21.0 software, with a significance level of 0.05. The results showed that the average satisfaction index of the patients was 95.73%, the minimum percentage was 4.27%. Pearson’s correlation of the groups shows a significant correlation for age for question P1 and P5, for phototype question P5 and for menopause for question P1 and P5, adapted from SROE. The P values for these parameters are considered statistically significant <0.05.
Downloads
Referências
AYRES, E.L.; SANDOVAL, M.H. Toxina Botulínica na Dermatologia. 1. Ed. Rio de Janeiro. Editora: Guanabara Koogan Ltda, 2016, 472p.
BRATZ, P.D.E; MALLET, E.K.V. Toxina Botulínica tipo A: Abordagens em saúde. Rev Saúde & Ciência em Ação. 2016; 3(2447–7079):58-70.
CHANG, B.L., WILSON, A.J., TAGLIENTI, A.J., CHANG, C.S., FOLSOM, N.; PERCEC, I. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes. Aesthetic Surgery Journal. 2016; 36(7):810-20.
FERREIRA, L.M.F.; TALARICO FILHO, S.; COSTA, R.O.; GODOY, A.; STEINER, D.; KEIRA, S.M.; PERCVORA, C. et al. Efficacy and tolerability of a new botulinum toxin type a for cosmetic treatment of dynamic facial wrinkles: a prospective, phase III multicenter study. Surgical & Cosmetic Dermatology, 2009; 1(2): 58-63.
FURLANI, E.A.T., SABOIA, D.B.; COSTA, M.L.M. Adaptação cultural do questionário de avaliação de resultados em rejuvenescimento de pele (Skin Rejuvenation Outcome Evaluation - SROE). Rev. Bras. Cir. Plást. 2020; 35(4): 402-07.
GAMA, J.T., ROSSETO, L.A., BRITO, N.B., VEIGA, D.F.; FERREIRA, L.M. Cross-cultural validation of the FACE-Q Satisfaction with Facial Appearance Overall Scale (FACE-Q SFAOS) in Brazilian rhytidoplasty patients. Clinics. 2020, 75:e1568.
GARBIN A.J.I, WAKAIAMA B., SALIBA T.A, GARBIN C.A.S. Harmonização orofacial e suas implicações na odontologia. Brazilian Journal of Surgery and Clinical Research, 2019; 27(2): 116-122.
GUBANOVA, E., TABET, M.H., BERGEROVA, Y., MOISEIEVA, O., CHEMERIS, A., SANCHES, E., SHAROVA, A., POSE, L.R., RAYMOND, R., CARLISLE, I.P. Assessment of Subject and Physician Satisfaction after Long-Term Treatment of Glabellar Lines with Abobotulinumtoxin A (Dysport/Azzalure): Primary Results of the APPEAL Noninterventional Study. (2018). Aesth Plast Surg. 2018; 42:1672-80.
KARBASSI, E., NAKHAEE, N., ZAMANIAN, M. The efficacy and complications of a new technique of Abobotulinum-toxin A (Dysport) injection in patients with glabellar lines. Journal of Cosmetic Dermatology. 2019; 18(1):55-58.
KESTEMONT, P., HILTON, S., ANDRIOPOULOS, B., PRYGOVA, I., THOMPSON, C., VOLTEAU, M., ASCHER, B. Alluzience in Glabellar Lines Study Group. Long-term efficacy and safety of liquid abobotulinumtoxina formulation for moderate-to-severe glabellar lines: A phase III, double-blind, randomized, placebo-controlled and open-label study. Aesthetic Surgery Journal. 2022; 42(3):301-11.
MAJID, O.W. Clinical use of botulinum toxins in oral and maxillofacial surgery. Int. J. Oral Maxillofac. Surg, Department Of Oral and Maxillofacial Surgery, College Of Dentistry, University Of Mosul, Mosul, Iraq, 2010; 39(3): 197-207.
MOLINA, B., GRANGIER, Y., MOLE, B., RIBE, N., MARTÍN DIAZ, L., PRAGER, W., KERROUCHE, N. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study. Journal of the European Academy of Dermatology and Venereology, 2014; 29(7):1382-88.
OLIVAS, M.A.; OLIVEIRA, A.O. Uso da toxina botulínica e dos preenchedores faciais pelo cirurgião-dentista: a antinomia causada pela lei do ato médico e lei regulamentadora do exercício da odontologia. Rev. Científic@ Universitas, 2019, 6(3):128.
OLIVEIRA, M.T.; MOLINA, R.O. Sorriso Gengival, quando a toxina botulínica pode ser utilizada. Rev. Odontol., 2022; 32 (2): 58-61.
OLIVEIRA G. Toxina Botulínica e suas complicações: Uma revisão de literatura. Monografia, 2019 (41f). Universidade Federal de Santa Catarina. Florianópolis, 2019.
OTTENHOFL, M.J.; VELDHUIZEN, I.J.; HENSBERGEN, L.J.; BLANKENSTEINJN, L.L.; BRAMER, W.; LEI, B.; HOOGBERGEN, M.M., HULST, R.W.J.; GIBBONS, C.J.S. The Use of the FACE-Q Aesthetic: A Narrative Review. Aesth Plast Surg. 2022; 46(6):2769-80.
SANTOS, C.S., MATTOS, R.M.; FULCO, T.O. Toxina botulínica tipo A e suas complicações na estética facial. Rev Episteme Transversalis. 2015; 6(2236–2649):73-84.
SMIT, R., GUBANOVA, E., KAUFMAN, J., LANDAU, M., MOLINA, B., ANDRIOPOULOS, B., MAISONOBE, P., PRYGOVA, I., REDAELLI, A. Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study. Journal of Clinical Aesthetic Dermatology. 2021; 14(2): E69-E88.
VASCONCELLOS, J.B., ANTELO, D.A.P.; OROFINO-COSTA, R. Tradução e validação transcultural de um questionário de qualidade de vida para avaliar procedimentos cosmiátricos faciais: versão para a língua portuguesa falada no Brasil. Surgical & Cosmetic Dermatology. 2022; 14:e20220101.
